Search details
1.
Targeted therapy against chemoresistant colorectal cancers: Inhibition of p38α modulates the effect of cisplatin in vitro and in vivo through the tumor suppressor FoxO3A.
Cancer Lett
; 344(1): 110-118, 2014 Mar 01.
Article
in English
| MEDLINE | ID: mdl-24215867
2.
Sorafenib inhibits p38α activity in colorectal cancer cells and synergizes with the DFG-in inhibitor SB202190 to increase apoptotic response.
Cancer Biol Ther
; 13(14): 1471-81, 2012 Dec.
Article
in English
| MEDLINE | ID: mdl-22986232
Results
1 -
2
de 2
1
Next >
>>